Pavlovian conditioning of multiple opioid-like responses in mice

Drug and Alcohol Dependence

Volumn 103, Issue 1-2, 2009, Pages 74-83

  Bryant, Camron D ^b   Roberts, Kristofer W ^a,c   Culbertson, Christopher S ^c   Le, Alan ^a   Evans, Christopher J ^a,c   Fanselow, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Associative learning; Cocaine; Context dependent; Expectancy; Open field; Opiate; Pain

Indexed keywords

COCAINE; FENTANYL CITRATE; MU OPIATE RECEPTOR AGONIST; OPIATE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; C57BL 6 MOUSE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; HOT PLATE TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PARAMETER; PAVLOVIAN CONDITIONING; PLACE PREFERENCE; PRIORITY JOURNAL; STIMULUS RESPONSE; STRAUB TAIL;

ANALGESIA; ANIMALS; CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; FENTANYL; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NARCOTICS;

MUS; RODENTIA;

EID: 65549098727     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.03.016     Document Type: Article

References (37)

1. Amanzio M., and Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci. 19 (1999) 484-494
2. Bardo M.T., and Valone J.M. Morphine-conditioned analgesia using a taste cue: dissociation of taste aversion and analgesia. Psychopharmacology (Berl) 114 (1994) 269-274
3. Beecher H.K. The powerful placebo. J. Am. Med. Assoc. 159 (1955) 1602-1606
4. Benedetti F., Colloca L., Torre E., Lanotte M., Melcarne A., Pesare M., Bergamasco B., and Lopiano L. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat. Neurosci. 7 (2004) 587-588
5. Bilbey D.J.L., and Grossman M.H. The anatomical basis of the Straub tail phenomenon. Br. J. Pharmacol. 15 (1960) 540-543
6. Bryant C.D., Zaki P.A., Carroll F.I., and Evans C.J. Opioids and addiction: emerging pharmaceutical strategies for reducing reward and opponent processes. Clin. Neurosci. Res. 5 (2005) 103-115
7. Carey R.J., Damianopoulos E.N., and Shanahan A.B. Cocaine conditioned behavior: a cocaine memory trace or an anti-habituation effect. Pharmacol. Biochem. Behav. (2008)
8. Celerier E., Laulin J.P., Corcuff J.B., Le Moal M., and Simonnet G. Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J. Neurosci. 21 (2001) 4074-4080
9. Childress A.R., McLellan A.T., and O'Brien C.P. Role of conditioning factors in the development of drug dependence. Psychiatr. Clin. North Am. 9 (1986) 413-425
10. de la Fuente-Fernandez R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., and Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293 (2001) 1164-1166
11. Dum J., and Herz A. Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol. Biochem. Behav. 21 (1984) 259-266
12. Gold L.H., Koob G.F., and Geyer M.A. Spatial pattern analysis reveals similarities between amphetamine conditioned and unconditioned locomotion. Behav. Pharmacol. 1 (1989) 209-220
13. Hayashi T., Ohashi K., and Tadokoro S. Conditioned drug effects to d-amphetamine- and morphine-induced motor acceleration in mice: experimental approach for placebo effect. Jpn. J. Pharmacol. 30 (1980) 93-100
14. Hodgson S., Hofford R., Buckman S., Wellman P., and Eitan S. Morphine-induced stereotyped thigmotaxis could appear as enhanced fear and anxiety in some behavioural tests. J. Psychopharmacol. (2009)
15. Levine J.D., Gordon N.C., and Fields H.L. The mechanism of placebo analgesia. Lancet 2 (1978) 654-657
16. Levine J.D., Feldmesser M., Tecott L., Lane S., and Gordon N.C. The role of stimulus intensity and stress in opioid-mediated analgesia. Brain Res. 304 (1984) 265-269
17. Mickley G.A., Mulvihill M.A., and Postler M.A. Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse. Psychopharmacology (Berl) 101 (1990) 332-337
18. Miller J.S., Kelly K.S., Neisewander J.L., McCoy D.F., and Bardo M.T. Conditioning of morphine-induced taste aversion and analgesia. Psychopharmacology (Berl) 101 (1990) 472-480
19. Mucha R.F., and Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berl) 86 (1985) 274-280
20. Nath C., Gupta M.B., Patnaik G.K., and Dhawan K.N. Morphine-induced straub tail response: mediated by central mu2-opioid receptor. Eur. J. Pharmacol. 263 (1994) 203-205
21. O'Brien C.P., Childress A.R., McLellan A.T., and Ehrman R. Classical conditioning in drug-dependent humans. Ann. N.Y. Acad. Sci. 654 (1992) 400-415
22. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., and Zubieta J.K. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55 (2007) 325-336
23. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., and Zubieta J.K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65 (2008) 220-231
24. Siegel S. Evidence from rats that morphine tolerance is a learned response. J. Comp. Physiol. Psychol. 89 (1975) 498-506
25. Siegel S. Morphine tolerance acquisition as an associative process. J. Exp. Psychol. Anim. Behav. Process 3 (1977) 1-13
26. Siegel S. Pavlovian conditioning analysis of morphine tolerance. NIDA Res. Monogr. (1978) 27-53
27. Siegel S., Baptista M.A., Kim J.A., McDonald R.V., and Weise-Kelly L. Pavlovian psychopharmacology: the associative basis of tolerance. Exp. Clin. Psychopharmacol. 8 (2000) 276-293
28. Skoubis P.D., Matthes H.W., Walwyn W.M., Kieffer B.L., and Maidment N.T. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice. Neuroscience 106 (2001) 757-763
29. Stewart J. Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-adminstration. Prog. Neuropsychopharmacol. Biol. Psychiatry 7 (1983) 591-597
30. Tirelli E., and Terry P. Amphetamine-induced conditioned activity and sensitization: the role of habituation to the test context and the involvement of Pavlovian processes. Behav. Pharmacol. 9 (1998) 409-419
31. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 12 (2007) 227-462
32. Valone J.M., Randall C.K., Kraemer P.J., and Bardo M.T. Olfactory cues and morphine-induced conditioned analgesia in rats. Pharmacol. Biochem. Behav. 60 (1998) 115-118
33. Vezina P., and Stewart J. Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field. Psychopharmacology (Berl) 91 (1987) 375-380
34. Wager T.D., Scott D.J., and Zubieta J.K. Placebo effects on human mu-opioid activity during pain. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 11056-11061
35. Wikler A. Dynamics of drug dependence, implications of a conditioning theory for research and treatment. Arch. Gen. Psychiatry 28 (1973) 611-616
36. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94 (1987) 469-492
37. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., Nichols T.E., and Stohler C.S. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J. Neurosci. 25 (2005) 7754-7762